Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Webster Groves who wrote (65998)	6/9/2007 9:43:56 PM
From: NOW	Respond to of 116555

"Doctors are the target for a large share of the estimated $20 billion the pharmaceutical industry spends each year on marketing. These marketing costs add to the higher prices we all pay for drugs and medical devices." health.yahoo.com Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies medicine.plosjournals.org i have a feeling you get the point

To: Webster Groves who wrote (65998)	6/9/2007 9:51:08 PM
From: NOW	Read Replies (1) \| Respond to of 116555

oh one more to remove any residual confusion you may have: "In 2000, pharmaceutical companies spent more than 15.7 billion dollars on promoting prescription drugs in the United States [2]. More than 4.8 billion dollars was spent on detailing, the one-on-one promotion of drugs to doctors by pharmaceutical sales representatives, commonly called drug reps. The average sales force expenditure for pharmaceutical companies is $875 million annually [3" pubmedcentral.nih.gov still think that "Drug companies do not MARKET to doctors"?